PREGASAFE

This brand name is authorized in Nigeria. It is also authorized in Ecuador.

Active ingredients

The drug PREGASAFE contains one active pharmaceutical ingredient (API):

1	Pregabalin UNII 55JG375S6M - PREGABALIN
	Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system.
	Read more about Pregabalin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-9007	Capsule	Pregasafe 75 Pregabalin Capsules CAP 75 mg 3 x 10's (in Alu-PVC/PVDC blisters)	White to off white color granular powder filled in size “4” hard gelatin capsules with White opaque body imprinted “PGBN” and Light Blue Opaque cap imprinted “75” with Black ink. Each hard gelatin capsule contains: Pregabalin USP 75 mg	21/12/2023
A4-9042	Capsule	Pregasafe 150 Pregabalin Capsules CAP 150 mg 3 x 10's (in Alu-PVC/PVDC blisters)	White to off white color granular powder filled in size “2” hard gelatin capsules with White opaque body imprinted “PGBN” and Light Blue Opaque cap imprinted “150” with Black ink. Each hard gelatin capsule contains: Pregabalin USP 150 mg	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BF02	Pregabalin	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids
Discover more medicines within N02BF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5001-MEE-0220, 5003-MEE-0320
NG	Registered Drug Product Database	A4-9007, A4-9042